{
    "other_tests": [
        {
            "procedure_name": "CASR gene mutation analysis",
            "date": "Not specified",
            "findings": "A novel heterozygous mutation (F180C) in exon 4 of the CASR gene was identified, which was unresponsive to increases in extracellular calcium concentrations.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Vitamin D supplementation",
            "date": "From January 2005 to January 2006",
            "findings": "Vitamin D supplementation resulted in a reduction of serum PTH levels to the normal range while serum calcium remained moderately elevated.",
            "changes_over_time": "Throughout the supplementation, serum PTH levels fell into the normal range, and serum 25(OH)D levels rose, but serum and ionized calcium levels stayed constant at moderately elevated levels."
        },
        {
            "procedure_name": "Biochemical assessment of infant",
            "date": "At birth",
            "findings": "The newborn presented with mildly elevated calcium, markedly elevated PTH and osteocalcin levels, and a 25(OH)D level of 26.2 nmol/liter.",
            "changes_over_time": "Serum PTH levels decreased over time as the hyperparathyroidism resolved; PTH levels were slightly elevated at day 48 and within normal range at day 70."
        }
    ]
}